These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
68 related articles for article (PubMed ID: 16153839)
1. Identification of a potent and selective 5-HT1B receptor antagonist. Wyman PA; Marshall HR; Flynn ST; King RJ; Thompson M; Smith PW; Hadley MS; Price GW; Scott CM; Dawson LA Bioorg Med Chem Lett; 2005 Nov; 15(21):4708-12. PubMed ID: 16153839 [TBL] [Abstract][Full Text] [Related]
4. Discovery of potent, orally bioavailable, selective 5-HT1A/B/D receptor antagonists. Ward SE; Eddershaw PJ; Scott CM; Gordon LJ; Lovell PJ; Moore SH; Smith PW; Starr KR; Thewlis KM; Watson JM J Med Chem; 2008 May; 51(10):2887-90. PubMed ID: 18433113 [TBL] [Abstract][Full Text] [Related]
5. QSAR study on dual 5-HT1A and 5-HT1B antagonists: an insight into the structural requirement for antidepressant activity. Dessalew N Arch Pharm (Weinheim); 2008 May; 341(5):314-22. PubMed ID: 18389517 [TBL] [Abstract][Full Text] [Related]
6. Characterisation of the selective 5-HT1B receptor antagonist SB-616234-A (1-[6-(cis-3,5-dimethylpiperazin-1-yl)-2,3-dihydro-5-methoxyindol-1-yl]-1-[2'-methyl-4'-(5-methyl-1,2,4-oxadiazol-3-yl)biphenyl-4-yl]methanone hydrochloride): in vivo neurochemical and behavioural evidence of anxiolytic/antidepressant activity. Dawson LA; Hughes ZA; Starr KR; Storey JD; Bettelini L; Bacchi F; Arban R; Poffe A; Melotto S; Hagan JJ; Price GW Neuropharmacology; 2006 Jun; 50(8):975-83. PubMed ID: 16581092 [TBL] [Abstract][Full Text] [Related]
7. Synthesis and serotonergic activity of variously substituted (3-amido)phenylpiperazine derivatives and benzothiophene-4-piperazine derivatives: novel antagonists for the vascular 5-HT1B receptor. Moloney GP; Garavelas A; Martin GR; Maxwell M; Glen RC Eur J Med Chem; 2004 Apr; 39(4):305-21. PubMed ID: 15072840 [TBL] [Abstract][Full Text] [Related]
8. Synthesis and SAR of highly potent dual 5-HT1A and 5-HT1B antagonists as potential antidepressant drugs. Kling A; Lange UE; Mack H; Bakker MH; Drescher KU; Hornberger W; Hutchins CW; Möller A; Müller R; Schmidt M; Unger L; Wicke K; Schellhaas K; Steiner G Bioorg Med Chem Lett; 2005 Dec; 15(24):5567-73. PubMed ID: 16219465 [TBL] [Abstract][Full Text] [Related]
9. Sulfonamides with the N-alkyl-N'-dialkylguanidine moiety as 5-HT7 receptor ligands. Zajdel P; Subra G; Verdie P; Gabzdyl E; Bojarski AJ; Duszyńska B; Martinez J; Pawłowski M Bioorg Med Chem Lett; 2009 Aug; 19(16):4827-31. PubMed ID: 19560916 [TBL] [Abstract][Full Text] [Related]
10. 5-HT1A and 5-HT1B receptor agonists and aggression: a pharmacological challenge of the serotonin deficiency hypothesis. de Boer SF; Koolhaas JM Eur J Pharmacol; 2005 Dec; 526(1-3):125-39. PubMed ID: 16310183 [TBL] [Abstract][Full Text] [Related]
11. Synthesis of potent and selective serotonin 5-HT1B receptor ligands. Huang Y; Bae SA; Roth BL; Laruelle M Bioorg Med Chem Lett; 2005 Nov; 15(21):4786-9. PubMed ID: 16143528 [TBL] [Abstract][Full Text] [Related]
12. Discovery of a potent and selective 5-ht5A receptor antagonist by high-throughput chemistry. Corbett DF; Heightman TD; Moss SF; Bromidge SM; Coggon SA; Longley MJ; Roa AM; Williams JA; Thomas DR Bioorg Med Chem Lett; 2005 Sep; 15(18):4014-8. PubMed ID: 16002289 [TBL] [Abstract][Full Text] [Related]
13. In vivo/ex vivo and behavioural study on central effects of 5-HT1B/1D and 5-HT1A antagonists in guinea pigs. Rex A; Voigt JP; Wicke KM; Fink H Pharmacol Biochem Behav; 2008 Jan; 88(3):196-204. PubMed ID: 17888505 [TBL] [Abstract][Full Text] [Related]
14. Bicyclic heteroarylpiperazines as selective brain penetrant 5-HT6 receptor antagonists. Ahmed M; Briggs MA; Bromidge SM; Buck T; Campbell L; Deeks NJ; Garner A; Gordon L; Hamprecht DW; Holland V; Johnson CN; Medhurst AD; Mitchell DJ; Moss SF; Powles J; Seal JT; Stean TO; Stemp G; Thompson M; Trail B; Upton N; Winborn K; Witty DR Bioorg Med Chem Lett; 2005 Nov; 15(21):4867-71. PubMed ID: 16143522 [TBL] [Abstract][Full Text] [Related]
15. 5-Thienyltryptamine derivatives as serotonin 5-HT1B/1D receptor agonists: potential treatments for migraine. Meng CQ; Rakhit S; Lee DK; Kamboj R; McCallum KL; Mazzocco L; Dyne K; Slassi A Bioorg Med Chem Lett; 2000 May; 10(9):903-5. PubMed ID: 10853656 [TBL] [Abstract][Full Text] [Related]
16. [N-methyl-3H3]AZ10419369 binding to the 5-HT1B receptor: in vitro characterization and in vivo receptor occupancy. Maier DL; Sobotka-Briner C; Ding M; Powell ME; Jiang Q; Hill G; Heys JR; Elmore CS; Pierson ME; Mrzljak L J Pharmacol Exp Ther; 2009 Jul; 330(1):342-51. PubMed ID: 19401496 [TBL] [Abstract][Full Text] [Related]
17. Regulatory molecules for the 5-HT3 receptor ion channel gating system. Yoshida S; Watanabe T; Sato Y Bioorg Med Chem; 2007 May; 15(10):3515-23. PubMed ID: 17391967 [TBL] [Abstract][Full Text] [Related]
18. Synthesis of new serotonin 5-HT7 receptor ligands. Determinants of 5-HT7/5-HT1A receptor selectivity. Medina RA; Sallander J; Benhamú B; Porras E; Campillo M; Pardo L; López-Rodríguez ML J Med Chem; 2009 Apr; 52(8):2384-92. PubMed ID: 19326916 [TBL] [Abstract][Full Text] [Related]
19. Synthesis of novel quinolone and quinoline-2-carboxylic acid (4-morpholin-4-yl-phenyl)amides: a late-stage diversification approach to potent 5HT1B antagonists. Horchler CL; McCauley JP; Hall JE; Snyder DH; Craig Moore W; Hudzik TJ; Chapdelaine MJ Bioorg Med Chem; 2007 Jan; 15(2):939-50. PubMed ID: 17126021 [TBL] [Abstract][Full Text] [Related]
20. Stimulation of the lateral hypothalamus produces antinociception mediated by 5-HT1A, 5-HT1B and 5-HT3 receptors in the rat spinal cord dorsal horn. Holden JE; Farah EN; Jeong Y Neuroscience; 2005; 135(4):1255-68. PubMed ID: 16165284 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]